Executive summary As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2
million estimated deaths from COVID-19, as reported by the Institute for Health Metrics and …

Introduction: India experienced 2 waves of COVID-19 pandemic caused by SARS-CoV-2
and reported the second highest caseload globally. Seroepidemiologic studies were done to …

Background There is a scarcity of reports of comparative analysis between the first and
second waves of the pandemic from any part of India. This article aims to comprehensively …

Background SARS-CoV-2 infection during pregnancy may cause adverse maternal,
neonatal and placental outcomes. While tissue hypoxia is often reported in COVID-19 …

Nucleocapsid antibody assays can be used to estimate SARS-CoV-2 infection prevalence in
regions implementing spike-based COVID-19 vaccines. However, poor sensitivity of …

Methods This study was conducted in Tamil Nadu, India, between December 14, 2021 and
January 7, 2022 among patients who underwent reverse transcription-PCR testing for SARS …

Background A previous community-based severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) serosurvey in Delhi in January 2021 reported a seroprevalence of 50.52 …

The effects of the coronavirus disease 2019 (COVID-19) pandemic on male fertility have
received considerable attention because human testes contain high levels of angiotensin …

Background: Estimating seroepidemiolgical prevalence of SARS-CoV-2 antibody is an
essential public health strategy. There is insufficient evidence of prevalence among those …

Background Seroprevalence studies have been carried out in many developed and
develo** countries to evaluate ongoing and past infection with severe acute respiratory …